Angelalign maintains share base in March; adds 300,000 options and 123,753 RSUs

Bulletin Express04-01

Angelalign Technology Inc. (Angelalign) filed its Monthly Return for Equity Issuer for March 2026 with Hong Kong Exchanges and Clearing Limited, confirming that no new shares were issued and no treasury shares were transferred during the period.

• Share capital unchanged – Authorised share capital stayed at 500.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to USD 50,000. – Issued share capital remained at 170.77 million ordinary shares; no shares were repurchased, cancelled, or held in treasury.

• Public-float intact – As at 31 March 2026, Angelalign met the minimum public-float requirement of 19.36 % of issued shares, in line with Main Board Rule 13.32D(1).

• Incentive-equity activity 1) Post-IPO Share Option Scheme (approved May 20 2021; last amended Aug 25 2025) – 300,000 new options granted in March. – Outstanding options rose to 3.15 million from 2.85 million a month earlier. – Maximum of 4.52 million shares remain available for future grants under this scheme.

2) Post-IPO RSU Scheme (approved May 20 2021; last amended Aug 25 2025) – 123,753 restricted share units (RSUs) granted on 30 March 2026. – 587,463 underlying shares are still available for future RSU grants. – No RSUs were converted into shares during the month, leaving issued share count unchanged.

No warrants, convertible securities, or other share-linked instruments were outstanding or exercised in March. The company’s equity structure therefore closed the month identical to February levels, with option and RSU grants providing potential dilution without immediate share issuance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment